Implementation of combined ultrasound and biochemistry for risk evaluation of chromosomal abnormalities during the first trimester in Sweden

Acta Obstetricia et Gynecologica Scandinavica

Volumn 93, Issue 9, 2014, Pages 868-873

  Ingvoldstad, Charlotta ^a   Öhman, Susanne Georgsson ^b   Lindgren, Peter ^a,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Down syndrome; ethical principles; information; Prenatal examinations; risk assessment

Indexed keywords

ADULT; AMNIOCENTESIS; ARTICLE; CHROMOSOME ANALYSIS; DOWN SYNDROME; FETUS; FETUS ECHOGRAPHY; FETUS HEART; FETUS KARYOTYPING; FIRST TRIMESTER PREGNANCY; FLUORESCENCE IN SITU HYBRIDIZATION; HIGH RISK PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MATERNAL AGE; NUCHAL TRANSLUCENCY MEASUREMENT; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PREGNANT WOMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; SWEDEN;

DOWN SYNDROME; ETHICAL PRINCIPLES; INFORMATION; PRENATAL EXAMINATIONS; RISK ASSESSMENT;

ADULT; CHROMOSOME DISORDERS; FEMALE; GESTATIONAL AGE; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SWEDEN; ULTRASONOGRAPHY, PRENATAL;

EID: 84905979070     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1111/aogs.12445     Document Type: Article

References (29)

1. Girriajan S,. Prenatal-age effects in Down syndrome. J Genet. 2009; 88: 1-7.
2. Tabor A, Alfirevic Z,. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther. 2010; 27: 1-7.
3. Nicolaides KH, Brizot ML, Snijders RJ,. Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester pregnancy. BJOG. 1994; 101: 782-6.
4. Saltvedt S, Almström H, Kublickas M, Valentin L, Bottinga R, Bui TH, et al. Screening for Down's syndrome based on maternal age or fetal nuchal translucency: a randomized controlled trial in 39 752 pregnancies. Ultrasound Obstet Gynecol. 2005; 25: 537-45.
5. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH,. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol. 1999; 13: 231-7.
6. Wright D, Spencer K, Kagan K, Torring N, Petersen B, Cristou A, et al. First trimester combined screening for trisomy 21 at 7-14 weeks' gestation. Ultrasound Obstet Gynecol. 2010; 36: 404-11.
7. Dormandy E, Hooper R, Michie S, Marteau TM,. Informed choice to undergo prenatal screening: a comparison of two hospitals conducting testing either as a part of a routine visit or requiring a separate visit. J Med Screen. 2002; 9: 109-14.
8. Dahl K, Kesmodel U, Hvidman L, Olesen F,. Informed consent: attitudes, knowledge and information concerning prenatal examinations. Acta Obstet Gynecol Scand. 2006; 85: 1414-9.
9. Dahl K, Kesmodel U, Hvidman L, Olesen F,. Informed consent: providing information about prenatal examinations. Acta Obstet Gynecol Scand. 2006; 85: 1420-5.
10. SFS 2006:351. Lagen om genetisk integritet. [The Law about Genetic Integrity]. Stockholm: Ministry of Social Welfare (Socialdepartementet) (in Swedish).
11. Swedish Council on Technology Assessment in Health Care. Metoder för tidig fosterdiagnostik [Methods for Early Fetal Diagnosis], SBU-report no. 182, 2006 (in Swedish). Stockholm.
12. National Board of Health and Welfare. Induced abortions, 2010. Published 2011. Available online at: http://www.socialstyrelsen.se/publikationer2011/2011- 6-1 (accessed on January 14, 2014).
13. Kublickas M, Crossley J, Aitken D,. Screening for Down's syndrome in the first trimester: combined risk calculation, methodology, and validation of a web-based system. Acta Obstet Gynecol Scand. 2009; 88: 635-8.
14. Health and Medical Services Act. Hälso- och sjukvårdslagen (1982: 762). Stockholm: Riksdagen. Available online at: http://www.riksdagen.se/ sv/Dokument-Lagar/Lagar/Svenskforfattningssamling/Halso-och-sjukvardslag-1982- sfs-1982-763/?bet=1982:763 (accessed on January 20, 2014) (in Swedish).
15. Beauchamp TL, Childress JF,. Principles in Biomedical Ethics. Oxford: Oxford University Press, 2013.
16. Marteau TM, Dormandy E, Michie S,. A measure of informed choice. Health Expect. 2001; 4: 99-108.
17. Michie S, Dormandy E, Marteau TM,. The multi-dimensional measure of informed choice: a validation study. Patient Educ Couns. 2002; 48: 87-91.
18. Bangsgaard L, Tabor A,. Do pregnant women and their partners make an informed choice about first trimester risk assessment for Down syndrome, and are they satisfied with the choice? Prenat Diagn. 2012; 32: 1-7.
19. SOSFS. Socialstyrelsens föreskrifter och allmänna råd om fosterdiagnostik och preimplantatorisk genetisk diagnostik 2012:20. [The National Board of Health and Welfare, Directions and General advices about Prenatal examinations and Preimplantation genetic diagnosis] (in Swedish).
20. Skirton H, Barr O,. Antenatal screening and informed choice: a cross-sectional survey of parents and professionals. Midwifery. 2010; 26: 596-602.
21. Garcia E, Timmermans DRM, van Leeuwen E,. Parental duties and prenatal screening: does an offer of prenatal screening lead women to believe that they are morally compelled to test? Midwifery. 2012; 28: e837-43.
22. Schoonen M, Wildshut H, Essink-Bot M-L, Peters I, Steegers E, de Koning H,. The provision of information and informed decision-making on prenatal screening for Down syndrome: a questionnaire- and register-based survey in a non-selected population. Patient Educ Couns. 2012; 87: 351-9.
23. Edwards A, Elwyn G, Mulley A,. Explaining risks: turning numerical data into meaningful pictures. BMJ. 2002; 324: 827-30.
24. Siegrist M, Cousin M-E, Keller C,. Risk communication, prenatal screening and prenatal diagnosis: the illusion of informed decision making. J Risk Res. 2008; 11: 87-97.
25. Ranji A, Dykes A-K, Ny P,. Routine ultrasound in investigations in the second trimester of pregnancy: the experiences of immigrant parents in Sweden. J Reprod Infant Psych. 2012; 30: 312-25.
26. Alfireviz Z, Sundberg K, Brigham S,. Amniocentesis and chorionic villus sampling for prenatal diagnosis. Cochrane Database Syst Rev. 2003; 3: CD003252.
27. Bennett IM, Baylson M, Kalkstein K, Gillespie G, Bellamy SL, Fleischman J,. Early abortion in family medicine: clinical outcomes. Ann Fam Med. 2009; 7: 527-33.
28. Baillie C, Smith J, Hewison J, Mason G,. Ultrasound screening for chromosomal abnormality-women's reactions to false positive results. Br J Health Psych. 2000; 5: 377-94.
29. Georgsson Öhman S, Saltvedt S, Grunewald C, Waldenström U, Olin Lauritsen S,. Pregnant women's responses to information about an increased risk of carrying a baby with Down's syndrome. Birth. 2006; 33: 64-73.